Correlation Between Monopar Therapeutics and Monte Rosa
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and Monte Rosa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and Monte Rosa into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and Monte Rosa Therapeutics, you can compare the effects of market volatilities on Monopar Therapeutics and Monte Rosa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Monte Rosa. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Monte Rosa.
Diversification Opportunities for Monopar Therapeutics and Monte Rosa
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Monopar and Monte is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Monte Rosa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monte Rosa Therapeutics and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Monte Rosa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monte Rosa Therapeutics has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Monte Rosa go up and down completely randomly.
Pair Corralation between Monopar Therapeutics and Monte Rosa
Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 4.01 times more return on investment than Monte Rosa. However, Monopar Therapeutics is 4.01 times more volatile than Monte Rosa Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Monte Rosa Therapeutics is currently generating about 0.03 per unit of risk. If you would invest 1,830 in Monopar Therapeutics on November 2, 2024 and sell it today you would earn a total of 2,420 from holding Monopar Therapeutics or generate 132.24% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Monopar Therapeutics vs. Monte Rosa Therapeutics
Performance |
| Timeline |
| Monopar Therapeutics |
| Monte Rosa Therapeutics |
Monopar Therapeutics and Monte Rosa Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monopar Therapeutics and Monte Rosa
The main advantage of trading using opposite Monopar Therapeutics and Monte Rosa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Monte Rosa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monte Rosa will offset losses from the drop in Monte Rosa's long position.| Monopar Therapeutics vs. Anebulo Pharmaceuticals | Monopar Therapeutics vs. Acrivon Therapeutics, Common | Monopar Therapeutics vs. Pmv Pharmaceuticals | Monopar Therapeutics vs. Molecular Partners AG |
| Monte Rosa vs. Nkarta Inc | Monte Rosa vs. Lyell Immunopharma | Monte Rosa vs. Generation Bio Co | Monte Rosa vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |